Trans Genic Inc. (TSE:2342) entered into share transfer agreement to acquire Lunapas LLC on September 7, 2021. As per terms of transaction, Lunapas LLC name will be changed to Lunapas Toxic Pathology Research Institute. March 31, 2021, Lunapas LLC reported Net assets of ?15.5 million, Total assets of ?19.736 million, Sales of ?39.521 million, Operating income of ?9.258 million and Net income of ?7.445 million. transaction is expected to complete on November 1, 2021. Acquisition will have a minor impact on the business results for the fiscal year ending March 2022. Trans Genic Inc. (TSE:2342) completed the acquisition of Lunapas LLC on November 1, 2021.